These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 9421696
41. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery. Koster A, Meyer O, Hausmann H, Kuppe H, Hetzer R, Mertzlufft F. J Clin Anesth; 2000 Jun; 12(4):324-7. PubMed ID: 10960207 [Abstract] [Full Text] [Related]
42. Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin. Keng TB, Chong BH. Br J Haematol; 2001 Aug; 114(2):394-6. PubMed ID: 11529862 [Abstract] [Full Text] [Related]
43. Ardeparin and danaparoid for prevention of deep vein thrombosis. Med Lett Drugs Ther; 1997 Oct 10; 39(1011):94-5. PubMed ID: 9379998 [No Abstract] [Full Text] [Related]
44. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Napolitano LM, Warkentin TE, Almahameed A, Nasraway SA. Crit Care Med; 2006 Dec 10; 34(12):2898-911. PubMed ID: 17075368 [Abstract] [Full Text] [Related]
45. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin]. Salmi L, Leroy-Matheron C, LeBesnerais P, Rosanval O, Duvaldestin P, Gouault-Heilmann M. Ann Fr Anesth Reanim; 2001 Nov 10; 20(9):799-802. PubMed ID: 11759322 [Abstract] [Full Text] [Related]
46. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin). Baumgärtel MW, Eichler P, Glöckner WM, Ranze O, Greinacher A. Eur J Haematol; 2000 Aug 10; 65(2):148-9. PubMed ID: 10966178 [No Abstract] [Full Text] [Related]
49. Heparin-induced thrombocytopenia and thrombosis. Patel VP, Bong M, Di Cesare PE. Am J Orthop (Belle Mead NJ); 2007 May 10; 36(5):255-60. PubMed ID: 17571830 [Abstract] [Full Text] [Related]
50. Heparin-induced thrombocytopenia: a ten-year retrospective. Warkentin TE. Annu Rev Med; 1999 May 10; 50():129-47. PubMed ID: 10073268 [Abstract] [Full Text] [Related]
51. Lepirudin use in a neonate with heparin-induced thrombocytopenia. Nguyen TN, Gal P, Ransom JL, Carlos R. Ann Pharmacother; 2003 Feb 10; 37(2):229-33. PubMed ID: 12549954 [Abstract] [Full Text] [Related]
57. Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia. Elalamy I, Tardy-Poncet B, Mulot A, de Maistre E, Pouplard C, Nguyen P, Cleret B, Gruel Y, Lecompte T, Tardy B, GEHT HIT Study Group. Thromb Res; 2009 Nov 28; 124(5):554-9. PubMed ID: 19410277 [Abstract] [Full Text] [Related]
58. Low molecular weight heparins and heparinoids. Eikelboom JW, Hankey GJ. Med J Aust; 2002 Oct 07; 177(7):379-83. PubMed ID: 12358583 [Abstract] [Full Text] [Related]